These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 34527540)

  • 1. Treatment of pulmonary arterial hypertension in children.
    Gorenflo M; Ziesenitz VC
    Cardiovasc Diagn Ther; 2021 Aug; 11(4):1144-1159. PubMed ID: 34527540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in targeted therapy for pulmonary arterial hypertension in children.
    Li L; Zhu X; Chen X; Gao J; Ding C; Zhang M; Ma S
    Eur J Pediatr; 2023 May; 182(5):2067-2076. PubMed ID: 36527480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Special Focus on Selexipag - Treatment of Pulmonary Arterial Hypertension.
    Sorensen LM; Wehland M; Kruger M; Simonsen U; Nassef MZ; Infanger M; Grimm D
    Curr Pharm Des; 2017; 23(34):5191-5199. PubMed ID: 28891448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.
    Spreemann T; Bertram H; Happel CM; Kozlik-Feldmann R; Hansmann G
    Pulm Circ; 2018; 8(1):2045893217743123. PubMed ID: 29099661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan.
    Schuuring MJ; Vis JC; Duffels MG; Bouma BJ; Mulder BJ
    Ther Clin Risk Manag; 2010 Sep; 6():359-66. PubMed ID: 20856682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances and future perspectives in therapeutic strategies for pulmonary arterial hypertension.
    Yao A
    J Cardiol; 2012 Nov; 60(5):344-9. PubMed ID: 23068290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases.
    Smukowska-Gorynia A; Gościniak W; Woźniak P; Iwańczyk S; Jaxa-Kwiatkowska K; Sławek-Szmyt S; Janus M; Paluszkiewicz J; Mularek-Kubzdela T
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Arterial Hypertension: Pathophysiology and Treatment.
    Lan NSH; Massam BD; Kulkarni SS; Lang CC
    Diseases; 2018 May; 6(2):. PubMed ID: 29772649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pediatric pulmonary arterial hypertension: A focus on the NO-sGC-cGMP pathway.
    Beghetti M; Gorenflo M; Ivy DD; Moledina S; Bonnet D
    Pediatr Pulmonol; 2019 Oct; 54(10):1516-1526. PubMed ID: 31313530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension.
    Wu S; Hoang HB; Yang JZ; Papamatheakis DG; Poch DS; Alotaibi M; Lombardi S; Rodriguez C; Kim NH; Fernandes TM
    Chest; 2022 Dec; 162(6):1360-1372. PubMed ID: 35841932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities.
    Badlam JB; Bull TM
    Ther Adv Chronic Dis; 2017 Feb; 8(2-3):47-64. PubMed ID: 28348727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
    Kaemmerer H; Gorenflo M; Huscher D; Pittrow D; Apitz C; Baumgartner H; Berger F; Bruch L; Brunnemer E; Budts W; Claussen M; Coghlan G; Dähnert I; D'Alto M; Delcroix M; Distler O; Dittrich S; Dumitrescu D; Ewert R; Faehling M; Germund I; Ghofrani HA; Grohé C; Grossekreymborg K; Halank M; Hansmann G; Harzheim D; Nemes A; Havasi K; Held M; Hoeper MM; Hofbeck M; Hohenfrost-Schmidt W; Jurevičienė E; Gumbienè L; Kabitz HJ; Klose H; Köhler T; Konstantinides S; Köestenberger M; Kozlik-Feldmann R; Kramer HH; Kropf-Sanchen C; Lammers A; Lange T; Meyn P; Miera O; Milger-Kneidinger K; Neidenbach R; Neurohr C; Opitz C; Perings C; Remppis BA; Riemekasten G; Scelsi L; Scholtz W; Simkova I; Skowasch D; Skride A; Stähler G; Stiller B; Tsangaris I; Vizza CD; Vonk Noordegraaf A; Wilkens H; Wirtz H; Diller GP; Grünig E; Rosenkranz S
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32414075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center.
    Sulica R; Fenton R; Cefali F
    Cardiol Ther; 2015 Dec; 4(2):209-18. PubMed ID: 26411969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat].
    Gratsianskaya SE; Valieva ZS; Martynyuk TV
    Ter Arkh; 2020 Oct; 92(9):77-84. PubMed ID: 33346435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors.
    Hoeper MM; Klinger JR; Benza RL; Simonneau G; Langleben D; Naeije R; Corris PA
    Respir Med; 2017 Jan; 122 Suppl 1():S18-S22. PubMed ID: 27887774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for pulmonary arterial hypertension.
    Parikh V; Bhardwaj A; Nair A
    J Thorac Dis; 2019 Sep; 11(Suppl 14):S1767-S1781. PubMed ID: 31632754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Pulmonary Arterial Hypertension in the Pediatric Patient.
    Ezekian JE; Hill KD
    Curr Cardiol Rep; 2019 Nov; 21(12):162. PubMed ID: 31781972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on pulmonary arterial hypertension pharmacotherapy.
    Velayati A; Valerio MG; Shen M; Tariq S; Lanier GM; Aronow WS
    Postgrad Med; 2016 Jun; 128(5):460-73. PubMed ID: 27232660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of pathogenetic therapy of pulmonary arterial hypertension].
    Chazova IE; Yarovoy SY; Danilov NM
    Ter Arkh; 2019 Dec; 91(12):4-9. PubMed ID: 32598582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.